Vogenx Inc. (VOGX) Stock Ticker
VOGX right now
Market factors today
Unlock the full VOGX picture
About Vogenx Inc.
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.
VOGX stock facts
| Ticker symbol | VOGX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $316.1M |
| CEO | James Green |
| Employees | 4 |
| Headquarters | Raleigh, NC, US |
| IPO date | 2026-08-12 |
| Website | www.vogenx.com |
What you can see for VOGX on Tickr
Live VOGX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the VOGX report.
Rankings
FAQ
What is the ticker symbol for Vogenx Inc.?
The ticker symbol for Vogenx Inc. is VOGX, listed on the NASDAQ.
What is VOGX?
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for…